Rheumatoid Arthritis Posts Page 2 on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Does tocilizumab treatment result in improved work productivity in patients with rheumatoid arthritis?

Posted by on Aug 13, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether tocilizumab (Actemra) treatment improves work productivity in patients with rheumatoid arthritis. They found that house workers treated with tocilizumab were more productive and better quality of life compared to patients taking synthetic disease-modifying drugs. Some background One of the...

Read More

Is an infliximab biosimilar safe and effective for methotrexate-resistant rheumatoid arthritis?

Posted by on Aug 13, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if an infliximab (Remicade) biosimilar is safe and effective to treat rheumatoid arthritis. They found that the infliximab biosimilar PF-06438179/GP1111 was similarly effective as standard infliximab and well tolerated. Some background Biosimilars are medicines that act in the same way as the original...

Read More

Assessing the potential of certolizumab pegol treatment for moderate/severe rheumatoid arthritis: is it a matter of time?

Posted by on Aug 13, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the timepoint at which certolizumab pegol treatment is effective in treating rheumatoid arthritis. They found that the effectiveness of certolizumab pegol treatment at 12 weeks predicts future treatment success at 52 weeks. Some background Certolizumab pegol (CZP) is a new biologic drug that blocks activity of...

Read More

Upadacitinib: a safe and effective rheumatoid arthritis treatment for patients resistant to csDMARDs

Posted by on Aug 9, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether upadacitinib is a safe and effective treatment for unresponsive patients with rheumatoid arthritis (RA). They concluded that upadacitinib improved RA symptoms in combination with csDMARDs and was well tolerated.  Some background ne type of medication used to treat rheumatoid arthritis...

Read More

Upadacitinib: a safe and effective medication to treat rheumatoid arthritis?

Posted by on Aug 9, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of upadacitinib for the treatment of rheumatoid arthritis. They found that upadacitinib is a safe and effective treatment for RA. Some background Disease-modifying anti-rheumatic drugs (DMARDs) are one of the standard medications to treat rheumatoid arthritis (RA). Biological...

Read More

Do glucocorticoid drugs affect bone density in patients with rheumatoid arthritis?

Posted by on Aug 9, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if glucocorticoid drugs affect bone mineral density in patients with rheumatoid arthritis. They found that the use of glucocorticoid drugs was not associated with changes in bone mineral density. Some background To treat rheumatoid arthritis (RA), patients are prescribed medication to reduce inflammation. One...

Read More

Sustaining remission in rheumatoid arthritis and identifying suitable patients for tapered treatment

Posted by on Jul 14, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the features of long-term disease remission in patients with rheumatoid arthritis (RA) on reduced treatment. The study concluded that disease activity, synovitis, rheumatoid factor and a history of smoking are associated with treatment failure. Some background Biological (b)DMARDs (disease-modifying...

Read More

Sarilumab versus adalimumab in the treatment of rheumatoid arthritis – a patient’s perspective

Posted by on Jul 14, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared sarilumab and adalimumab for the treatment of rheumatoid arthritis (RA). They found that sarilumab–treated patients reported greater improvements in overall health and disability, quality of life and pain scores. Some background Treatment of rheumatoid arthritis (RA) involves medications to reduce...

Read More

Do glucocorticoid drugs increase the risk of adverse events in patients with rheumatoid arthritis?

Posted by on Jul 14, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated adverse events associated with glucocorticoid medications in patients with rheumatoid arthritis. The study found that patients with RA have an increased incidence of adverse events associated with the use of glucocorticoids. Some background Treatment of rheumatoid arthritis (RA) involves taking...

Read More

Non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatoid arthritis: a potential risk factor for stroke or heart attack?

Posted by on Jul 14, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of heart attack or stroke in patients with rheumatoid arthritis (RA). They found that non-selective NSAIDs were associated with an increased risk of both stroke and heart attack in RA patients. Some background One type of medication used to...

Read More

Assessing cancer risk in patients using disease-modifying drugs and corticosteroids to treat rheumatoid arthritis

Posted by on Jul 14, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the risk of skin cancer in patients taking disease-modifying drugs (DMARDs) and corticosteroids to treat rheumatoid arthritis (RA). They concluded that certain DMARDs and corticosteroids are associated with an increased risk of non-melanoma skin cancer. Some background Rheumatoid arthritis (RA) is a...

Read More